Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bence Sipos

Showing results (121-130 of 206) with videos related to

Pageof 21
Sort By:
BJU International|February 18, 2009
Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel densityCarsten Maik Naumann, Amr Al-Najar, Ibrahim Alkatout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival timesGlen Kristiansen, Juliane Jacob, Ann-Christin Buckendahl, et al.
Molecular & Cellular Proteomics : MCP|December 9, 2015
Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected CellsJuliet Padden, Maike Ahrens, Julia Kälsch, et al.
The American Journal of Surgical Pathology|March 16, 2005
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changesMartin Anlauf, Daniel Wieben, Aurel Perren, et al.
Cancer Cell|April 13, 2011
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancerMarina Lesina, Magdalena U Kurkowski, Katharina Ludes, et al.
International Journal of Cancer|October 25, 2011
Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinomaJan Sperveslage, Sunna Frank, Carola Heneweer, et al.
Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2014
Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomasIbrahim Alkatout, Juliane Friemel, Barbara Sitek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20Björn Konukiewitz, Anna Melissa Schlitter, Moritz Jesinghaus, et al.
International Journal of Oncology|June 4, 2013
Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancerSufian S Ahmad, Jörg Glatzle, Khaled Bajaeifer, et al.
Pageof 21

Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
BJU International|February 18, 2009
Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel densityCarsten Maik Naumann, Amr Al-Najar, Ibrahim Alkatout, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival timesGlen Kristiansen, Juliane Jacob, Ann-Christin Buckendahl, et al.
Molecular & Cellular Proteomics : MCP|December 9, 2015
Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected CellsJuliet Padden, Maike Ahrens, Julia Kälsch, et al.
The American Journal of Surgical Pathology|March 16, 2005
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changesMartin Anlauf, Daniel Wieben, Aurel Perren, et al.
Cancer Cell|April 13, 2011
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancerMarina Lesina, Magdalena U Kurkowski, Katharina Ludes, et al.
International Journal of Cancer|October 25, 2011
Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinomaJan Sperveslage, Sunna Frank, Carola Heneweer, et al.
Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2014
Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomasIbrahim Alkatout, Juliane Friemel, Barbara Sitek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20Björn Konukiewitz, Anna Melissa Schlitter, Moritz Jesinghaus, et al.
International Journal of Oncology|June 4, 2013
Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancerSufian S Ahmad, Jörg Glatzle, Khaled Bajaeifer, et al.
Pageof 21